Faes Farma S.A [FAE] vs Almirall S.A [ALM] Detailed Stock Comparison

Faes Farma S.A.

BME
Loading...

Almirall S.A.

BME
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Faes Farma S.A. wins in 9 metrics, Almirall S.A. wins in 11 metrics, with 0 ties. Almirall S.A. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Faes Farma S.A. Almirall S.A. Better
P/E Ratio (TTM) 19.60 58.64 Faes Farma S.A.
Price-to-Book Ratio 2.05 1.86 Almirall S.A.
Debt-to-Equity Ratio 58.11 23.30 Almirall S.A.
PEG Ratio 14.10 23.08 Faes Farma S.A.
EV/EBITDA 16.41 13.48 Almirall S.A.
Profit Margin (TTM) 12.70% 4.14% Faes Farma S.A.
Operating Margin (TTM) 0.64% 1.97% Almirall S.A.
EBITDA Margin (TTM) 0.64% 1.97% Almirall S.A.
Return on Equity 10.82% 3.10% Faes Farma S.A.
Return on Assets (TTM) 5.06% 1.90% Faes Farma S.A.
Free Cash Flow (TTM) $54.85M $37.15M Faes Farma S.A.
Dividend Yield 4.09% 1.67% Faes Farma S.A.
1-Year Return 15.38% 31.68% Almirall S.A.
Price-to-Sales Ratio (TTM) 2.43 2.48 Faes Farma S.A.
Enterprise Value $1.84B $2.74B Almirall S.A.
EV/Revenue Ratio 2.94 2.46 Almirall S.A.
Gross Profit Margin (TTM) 63.93% 78.50% Almirall S.A.
Revenue per Share (TTM) $2 $5 Almirall S.A.
Earnings per Share (Diluted) $0.25 $0.22 Faes Farma S.A.
Beta (Stock Volatility) 0.32 0.19 Almirall S.A.

Faes Farma S.A. vs Almirall S.A. Stock Performance Analysis

Loading Price Chart...

FAE
ALM

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Faes Farma S.A.-1.23%-2.24%6.90%-6.07%6.90%-8.05%
Almirall S.A.-0.93%-0.47%11.78%-0.16%0.79%-1.40%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Faes Farma S.A.15.38%50.00%38.33%75.18%77.12%-48.94%
Almirall S.A.31.68%36.63%-2.60%-9.40%65.19%-15.31%

Performance & Financial Health Analysis: Faes Farma S.A. vs Almirall S.A.

MetricFAEALM
Market Information
Market Cap i€1.51B€2.76B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i128,574140,818
90 Day Avg. Volume i149,177142,299
Last Close€4.80€12.72
52 Week Range€4.09 - €5.44€9.41 - €13.98
% from 52W High-11.76%-9.01%
All-Time High€19.40 (Feb 05, 2007)€19.09 (Dec 28, 2015)
% from All-Time High-75.26%-33.37%
Growth Metrics
Quarterly Revenue Growth0.48%0.11%
Quarterly Earnings Growth-0.81%1.39%
Financial Health
Profit Margin (TTM) i0.13%0.04%
Operating Margin (TTM) i0.01%0.02%
Return on Equity (TTM) i0.11%0.03%
Debt to Equity (MRQ) i58.1123.30
Cash & Liquidity
Book Value per Share (MRQ)€2.39€6.92
Cash per Share (MRQ)€0.42€1.58
Operating Cash Flow (TTM) i€78.49M€174.46M
Levered Free Cash Flow (TTM) i€17.98M€34.95M
Dividends
Last 12-Month Dividend Yield i4.09%1.67%
Last 12-Month Dividend i€0.22€0.18

Valuation & Enterprise Metrics Analysis: Faes Farma S.A. vs Almirall S.A.

MetricFAE (Apr 24, 2026)ALM (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i19.6058.64
Forward P/E i14.1023.08
PEG Ratio i14.1023.08
Price to Sales (TTM) i2.432.48
Price to Book (MRQ) i2.051.86
Market Capitalization
Market Capitalization i€1.51B€2.76B
Enterprise Value i€1.84B€2.74B
Enterprise Value Metrics
Enterprise to Revenue i2.942.46
Enterprise to EBITDA i16.4113.48
Risk & Other Metrics
Beta i0.320.19
Book Value per Share (MRQ) i€2.39€6.92

Financial Statements Comparison: Faes Farma S.A. vs Almirall S.A.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricFAE (2025)ALM (2025)
Revenue/Sales i610.46M1.11B
Cost of Goods Sold i214.55M236.47M
COGS % of Revenue i35.1%21.3%
Gross Profit i395.91M871.61M
Gross Margin i64.9%78.7%
Research & Development iN/A96.00M
Operating Income (EBIT) i88.83M66.75M
Operating Margin i14.6%6.0%
EBITDA i119.87M221.67M
EBITDA Margin i19.6%20.0%
Pre-Tax Income i85.41M74.45M
Pre-Tax Income % of Revenue i14.0%6.7%
Income Tax i5.75M28.29M
Income Tax % of Revenue i0.9%2.6%
Net Income (Profit) i79.66M46.15M
Profit Margin i13.0%4.2%

Balance Sheet & Liquidity Metrics

MetricFAE (2025)ALM (2025)
Cash & Equivalents i117.31M337.77M
Total Current Assets i482.40M713.98M
Total Current Assets % of Revenue i79.0%64.4%
Total Current Liabilities i184.88M350.64M
Total Current Liabilities % of Revenue i30.3%31.6%
Long-Term Debt i373.73M324.81M
Long-Term Debt % of Revenue i61.2%29.3%
Total Shareholders Equity i745.59M1.49B
Retained Earnings i194.59M46.15M
Retained Earnings % of Revenue i31.9%4.2%
Property, Plant & Equipment i353.31M15.87M

Cash Flow Statement Comparison

MetricFAE (2025)ALM (2025)
Operating Cash Flow i96.58M60.83M
Operating Cash Flow % of Revenue i15.8%5.5%
Capital Expenditures i-21.46M-34.91M
Free Cash Flow i54.85M37.15M
FCF Margin i9.0%3.4%
Debt Repayment iN/A-10.00M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricFAEALM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i311.26M214.63M
Float Shares i229.08M75.35M
% Held by Insiders i20.35%64.96%
% Held by Institutions i15.69%18.17%
% Held by Public i63.96%16.87%

Dividend Analysis & Yield Comparison: Faes Farma S.A. vs Almirall S.A.

MetricFAEALM
Last 12-Month Dividend i€0.22€0.18
Last 12-Month Dividend Yield i4.09%1.67%
3-Year Avg Annual Dividend i€0.17€0.18
3-Year Avg Dividend Yield i2.22%1.97%
3-Year Total Dividends i€0.50€0.54
Ex-Dividend DateJan 08, 2026May 15, 2025